Schlatter J
Pharmacie, Hôpital Universitaire Necker-Enfants Malades, 149, rue de Sèvres, 75015 Paris, France.
Arch Pediatr. 2018 Oct;25(7):405-410. doi: 10.1016/j.arcped.2018.08.005. Epub 2018 Sep 21.
The complexity and vulnerability of the pediatric population make them unique to risk management. Risk analysis is particularly demanding here and requires comprehensive identification of hazardous situations. Few data are published on methods to prevent medication errors in pediatric inpatients, reducing the possibility for healthcare institutions to prioritize the actions to take. This paper summarizes the proactive risk analysis methods described in the literature, the failures identified, and the corrective actions applied to reduce the risks in pediatrics.
儿科人群的复杂性和脆弱性使其在风险管理方面具有独特性。在此，风险分析的要求尤为苛刻，需要全面识别危险情况。关于预防儿科住院患者用药错误方法的公开数据很少，这降低了医疗机构确定优先采取行动的可能性。本文总结了文献中描述的前瞻性风险分析方法、已识别的失误以及为降低儿科风险而采取的纠正措施。
